Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)thio]phenylacetyl]-L-cysteine
US4866082A · kind A · utility
1Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 1988 |
| Grant date | Sep 12, 1989 |
| Priority date | — |
| Expiry date | Apr 6, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/425
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for modifying the balance between bone production and bone resorption in a host animal by administration of (-)-N-[[(5-chloro-benzothiazolyl)-thio]phenylacetyl]-L-cysteine to inhibit bone loss.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.